Results 91 to 100 of about 51,719 (196)

Treatment of Gram negative meningitis with cefotaxime

, 1983
The authors report on the successful cefotaxime treatment (one of the newer cephalosporins) of K. pneumoniae meningitis which developed while the patient was under treatment with an older cefalosporin ...
Glauser, M. P., Mirimanoff, R. O., de Tribolet, N.   +2 more
core   +1 more source

Pharmacokinetics of Cefotaxime and Desacetylcefotaxime in Patients with Liver Disease

, 1990
The dispositions of cefotaxime and its metabolite desacetylcefotaxime were investigated in patients with different forms of chronic parenchymal liver disease (CPLD).
Jordan L. Cohen, Richard J. Ko, Maria Appleman, Fred R. Sattler, Evangelos Akriviadis, Robert T. Kodal, Sharon Nichols, Bruce Runyon   +7 more
core  

Synergistic Antibacterial and Antibiofilm Effects of (KW)₄ in Combination With Antibiotics Against Listeria monocytogenes. [PDF]

J Pept Sci
Park J, Kang DD, Lim Y, Oh JH, Kim H, Moon C, Lee J, Choi S, Park Y.   +8 more
europepmc   +1 more source

Animal husbandry and environmental conditions are associated with cefotaxime-resistant Escherichia coli in yard soil in peri-urban Malawi. [PDF]

PLOS Glob Public Health
Budden E, Niven CG, Clark B, Floess E, Chirwa B, Matekenya M, Cadono S, Chavula J, Chisamanga V, Dzinkambani A, Kaponda C, Ngondo N, Patterson N, Symon S, Chunga BA, Holm RH, Chigwechokha P, de Los Reyes FL, Workman CL, Harris AR, Ercumen A.   +20 more
europepmc   +1 more source

A DNA Tetrahedron-Delivered miR-17-5p mimic exerts dual anti-inflammatory and Anti-<i>Pseudomonas aeruginosa</i> effects in cystic fibrosis. [PDF]

Noncoding RNA Res
Ye Y, Sun Y, Shahrour H, Oglesby I, Zheng Y, Greene CM.   +5 more
europepmc   +1 more source

Comparative significance of piperacillin-tazobactam and cefotaxime-tazobactam in the treatment of respiratory tract infections in the elderly. [PDF]

Front Pharmacol
Peng M, Liang H, Chen J, Zhang J, Qin D.
europepmc   +1 more source

Favorable clinical outcome of recurrent deep chest wall infection caused by pan-resistant Klebsiella pneumoniae treated with cefotaxime plus polymyxin B: a case report. [PDF]

Rev Soc Bras Med Trop
Bomfim SA, Echeverria JES, Silva RCCD, Tetila AF, Melo ALF, Souza GHA, Tirloni CAS, Simionatto S.   +7 more
europepmc   +1 more source

Simulating an intravenous-to-oral cefotaxime-to-cefditoren/cefuroxime switch: an <i>in vitro</i> pharmacodynamic approach against selected <i>Streptococcus pneumoniae</i> strains with defined susceptibility profiles. [PDF]

Front Pharmacol
González N, Manceras Jiménez E, Giménez MJ, Alou L, Coronel P, Gómez-Rubio E, Gómez-Lus ML, Sevillano D.   +7 more
europepmc   +1 more source

Necrotizing Enterocolitis in Term Neonates with Critical Congenital Heart Disease: Associated Risk Factors and Clinical Outcomes. [PDF]

J Cardiovasc Dev Dis
Kangel D, Recep E, Çevlik B, Oğuz AS, Tan Recep BZ, Genç HZ, Öztürk DY, Hatemi AC, Öztürk E.   +8 more
europepmc   +1 more source

<i>Shigella</i> infections in the era of antimicrobial resistance: Insights into cephalosporin use. [PDF]

New Microbes New Infect
Wang W, Qin Y, Wang Y, Li X, Kuang D, Rajaofera MJN.   +5 more
europepmc   +1 more source